Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor

European Journal of Immunology

Volumn 29, Issue 1, 1999, Pages 30-37

  Dyall, Ruben ^a   Vasovic, Ljiljana V ^a,d   Clynes, Raphael A ^b   Nikolić Žugić, Janko ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c Weill Cornell Graduate School of Biomedical Sciences   (United States)

^d LENOX HILL HOSPITAL   (United States)

Author keywords

Antibody; CD8+ cell; Fc R; Macrophage; Tumor regression

Indexed keywords

CANCER ANTIBODY; CD11B ANTIGEN; CD8 ANTIGEN; FC RECEPTOR; MONOCLONAL ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; TUMOR REGRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CD8-POSITIVE T-LYMPHOCYTES; CHICKENS; HEMATOPOIETIC STEM CELLS; KINETICS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA; MACROPHAGE-1 ANTIGEN; MICE; MICE, KNOCKOUT; OVALBUMIN; RECEPTORS, IGG; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0032895775     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199901)29:01<30::AID-IMMU30>3.0.CO;2-D     Document Type: Article

References (22)

1. Lynch, A. S. and Houghton, A. N., Cancer immunology. Curr. Opin. Oncol. 1993. 5: 145-151.
2. Coulie, P., Weynants, P., Lehmann, F., Herman, J., Brichard, V., Wolfel, T., Van Pel, A., De Plaen, E., Brasseur, R. and Boon, T., Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. J. Immunother. 1993. 14: 104-109.
3. Jurčić, J. G., Scheinberg, D. A. and Houghton, A. N., Monoclonal antibody therapy of cancer. In Pineda, A., Longo, D. and Charner, B. (Eds.), Cancer Chemotherapy and Biological Response Modifiers 1997, pp 195-216.
4. Manson, L. A., Anti-tumor immune responses of the tumor-bearing host: the case for antibody-mediated immunologic enhancement. Clin. Immunol. Immunopathol. 1994. 72:1-8.
5. Egorov, O. S., Liu, Y., Sargent, E. E., Drizlikh, G. I. and Egorov, I. K., Screening mouse mutations for resistance to cancer metastasis. Immunogenetics 1992. 36: 219-223.
6. Vallera, D. A., Taylor, P. A., Aukerman, S. L. and Blazar, B. R., Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2. Cancer Res. 1993. 53: 4273-4280.
7. Grooten, J. and Fiers, W., Acquisition by the murine host of responsiveness toward various neoplastic cell lines, but not toward self, through adoptive transfer of a helper T-lymphocyte clone with antiself specificity. Cancer Res. 1989. 49: 3872-3878.
8. Zhou, F., Rouse, B. T. and Huang, L., Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study. Cancer Res. 1992. 52: 6287-6291.
9. Moore, M. W., Carbone, F. R. and Bevan, M. J., Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988. 54: 777-785.
10. + cells in eliminating an established tumor. Eur. J. Immunol. 1997. 27: 374-382.
11. Dialynas, D. P., Quan, Z. S., Wall, K. A., Pierres, A., Quintans, J., Loken, M. R., Pierres, M. J. and Fitch, F. W., Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 1983. 131: 2445-2451.
12. Sandor, M. and Lynch, R. G., Lymphocyte Fc receptors: the special case of T cells. Immunol. Today 1993. 14: 227-231.
13. Takai, T., Li, M., Sylvestre, D., Clynes, R. and Ravetch, J. V., FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 1994. 76: 519-529.
14. Ravetch, J. V., Fc receptors. Curr. Opin. Immunol. 1997. 9: 121-125.
15. Mamalaki, C., Tanaka, Y., Corbella, P., Chandler, P., Simpson, E. and Kioussis, D., T cell deletion follows chronic antigen specific T cell activation in vivo. Int. Immunol. 1993. 5: 1285-1292.
16. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J. and Carbone, F. R., T cell receptor antagonist peptides induce positive selection. Cell 1994. 76:17-27.
17. Griffin, F. M. Jr. and Mulinax, P. J., In vivo activation of macrophage C3 receptors for phagocytosis. J. Exp. Med. 1985. 162: 352-357.
18. Griffin, F. M. Jr. and Mulinax, P. J., Augmentation of macrophage complement receptor function in vitro. J. Immunol. 1985. 135: 344-349.
19. + single-positive thymocytes require the thymus to produce long-lived, functional T cells. J. Exp. Med. 1995. 181: 235-245.
20. Dyall, R., Vasovic, L. V., Molano, A. and Nikolić-Žugić, J., CD4-independent priming of murine CTL by optimal MHC class l-restricted peptides in vivo. Int. Immunol. 1995. 7: 1205-1212.
21. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G. and Rammensee, H.-G., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991. 352: 290-296.
22. b-restricted cytotoxic T-lymphocyte recognition epitopes in simian virus 40 T antigen. J. Virol. 1992. 66: 440-449.